HK inno.N has begun selling its K-CAB tablet, a gastroesophageal reflux disease treatment, in Peru, the pharmaceutical company said Monday.
HK inno.N inked a technology transfer deal with Brazil-based Eurofarma for its K-CAB tablets, a gastroesophageal reflux disease treatment.
HK inno.N signed an agreement with Novacell Technology to jointly develop treatments for autoimmune diseases, the Korean maker of hangover helpers and pharmaceuticals said Wednesday.
HK inno.N, the Korean maker of hangover helpers and pharmaceuticals, finished its first day of trading up 16 percent from its offering price of 59,000 won ($52).
HK inno.N aims to go public early next month as Kosdaq stock, the Korean maker of hangover helpers and pharmaceuticals said Thursday.
Korea JoongAng Daily Sitemap